Skip to main content Skip to main navigation menu Skip to site footer
Case Report
Published: 22-02-2022

Nutritional support in a patient with Cytomegalovirus (CMV) enterocolitis in the acquired immunodeficiency syndrome (AIDS)

Academic of Medicine at the University Lutheran of Brazil
Academic of Medicine at the University Lutheran of Brazil
Academic of Medicine at the University Lutheran of Brazil
Academic of Medicine at the University Lutheran of Brazil
Academic of Medicine at the University Lutheran of Brazil
Academic of Medicine at the University Lutheran of Brazil
Academic of Medicine at the University Lutheran of Brazil
Academic of Medicine at the University Lutheran of Brazil
Academic of Medicine at the University Lutheran of Brazil
Nutrologist Physician at the Nutrology Service of Hospital Ernesto Dornelles
L-glutamine Enterocolitis Cytomegalovirus

Abstract

Introduction: Several diseases of the gastrointestinal tract should be taken into account in patients with the human immunodeficiency virus (HIV) since diarrhea negatively affects the patient's quality of life. Given this condition, Cytomegalovirus (CMV) enterocolitis may present with fever, weight loss, intermittent diarrhea, and hematochezia. Objective: This study aimed to report the effect of enteral supplementation with L-glutamine and oligomeric enteral nutritional therapy (ENT) formula in patients with cytomegalovirus, and with refractory diarrhea associated with wasting HIV syndrome. Methods: The information contained in this report was obtained through a review of the medical record and a review of the literature. Results: This is the report of S. S. A, a female, 27 years old, who was admitted to Hospital Ernesto Dornelles, in Porto Alegre, from 11/15/2020 to 12/30/2020, diagnosed with HIV for a month, without undergoing treatment. The patient was hospitalized due to worsening abdominal pain starting 2 days ago, with diarrhea and mental confusion. On physical examination, she presented pain in the lower abdominal region. From anthropometry, the measured weight of 67kg, the self-reported height of 1.67m, and BMI of 24kg/m2. On 11/17, she presented PCR-CMV positive for CMV and underwent laparotomy for pneumoperitoneum with endarterectomy due to perforation of the distal ileum. In use of ganciclovir for CMV. On December 2, the upper digestive endoscopy with biopsy showed an esophagus with the Z-line located close to the diaphragmatic clamping, with esophageal mucosa with extensive, friable, serpiginous ulcers, being a valuable diagnosis in CMV enterocolitis. From 12/04 to 12/08, she used exclusive enteral L-glutamine 20g/day. On 12/09, she started an oligomeric formula via the low-flow enteral route with progression to the caloric and protein targets. On 12/30, the patient had improved diarrhea, with a depressible and painless abdomen, and had been discharged. Final Considerations: In the present report, it was obtained a beneficial effect with the nutritional intervention using L-glutamine and enteral oligomeric formula in the treatment of diarrhea. Thus, the improvement in the condition in just 5 days can be explained by the rhythm of the enterocyte cell cycle, which occurs in an average period of 3 days, and it is possible that the 4 day period of nutritional intervention is sufficient to increase endogenous levels of L-glutamine.

Metrics

Metrics Loading ...

References

  1. LIMA, D.B. de et al. Clinical profile of Cytomegalovirus (CMV) Enterocolitis in Acquired Immunodeficiency Syndrome (AIDS). Revista da Associação Médica Brasileira [online]. V. 46, n. 1, pp. 1-6, 2000.
  2. CHEUNG, T. W.;TEICH, S. A. (1999). Cytomegalovirus infection in patients with HIV infection. The Mount Sinai journal of medicine, New York, 66(2), 113-124.
  3. SILVA, R. P.; COSTA, P. S. S.F.; BURGOS, M. G. P. A. Suplementação dietética com L-glutamina e fibra solúvel na diarreia crônica refratária de paciente com aids: relato de caso. DST j. bras. doenças sex. transm; 23(3): 146-148, 2011.
  4. Camilleri M. Human Intestinal Barrier: Effects of Stressors, Diet, Prebiotics, and Probiotics. Clin Transl Gastroenterol. 2021 Jan 25;12(1):e00308. doi: 10.14309/ctg.0000000000000308. PMID: 33492118; PMCID: PMC7838004.
  5. Yu Y, Clippinger AJ, Pierciey FJ Jr, Alwine JC. Viruses and metabolism: alterations of glucose and glutamine metabolism mediated by human cytomegalovirus. Adv Virus Res. 2011;80:49-67. doi: 10.1016/B978-0-12-385987-7.00003-8. PMID: 21762821.
  6. Leite RD, Lima NL, Leite CA, Farhat CK, Guerrant RL, Lima AA. Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trial. Arq Gastroenterol. 2013 Jan-Mar;50(1):56-63. doi: 10.1590/s0004-28032013000100011. PMID: 23657308.
  7. Zhou Q, Verne ML, Fields JZ, Lefante JJ, Basra S, Salameh H, Verne GN. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019 Jun;68(6):996-1002. doi: 10.1136/gutjnl-2017-315136. Epub 2018 Aug 14. PMID: 30108163.
  8. Bushen OY, Davenport JA, Lima AB, Piscitelli SC, Uzgiris AJ, Silva TM, Leite R, Kosek M, Dillingham RA, Girao A, Lima AA, Guerrant RL. Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil. Clin Infect Dis. 2004 Jun 15;38(12):1764-70. doi: 10.1086/421394. Epub 2004 May 26. Erratum in: Clin Infect Dis. 2004 Aug 15;39(4):607. PMID: 15227625.

How to Cite

Bisotto, J. da R., Gorini, A. P. C., Claudino, L. D., Zatt, J. V. D. P., Boer, D. T. de, Kern, G. M., Abdalla, Y. A., Fontana, V. C., Lutz, L. M., & Coelho, J. C. (2022). Nutritional support in a patient with Cytomegalovirus (CMV) enterocolitis in the acquired immunodeficiency syndrome (AIDS). International Journal of Nutrology, 15(1). https://doi.org/10.54448/ijn22109